Search Tag: Kendell R. Sprott
2022 23 Jun
Tevogen Bio, a late-stage biotechnology company specializing in developing cell and gene therapies in oncology, neurology, and virology announced that its Board of Directors has appointed Kendell R. Sprott, M.D., J.D., to its Corporate Advisory Board. Most recently, Dr. Sprott served six years as President and CEO at Matheny Medical and Educational...Read more